Background: The purpose of this study is to understand the incidence, related factors, and the prognosis factors in order to avoid risk, proper method of diagnosis and treatment and reduce complications and provide the basis. Methods: 85 Vulvar cancer (VC) patients treated in our hospital from 2002.10 to 2012.10 were collected and analyzed by retrospective comparative methods. SPSS19.0 application software was used for the statistical analysis. The clinical data are analyzed by chi-square and F test statistic methods. P < 0.05 was a significant difference between the judgment standard. Results: During 10 years, we treated 3391 cases of the primary malignant tumors including 85 VC cases; VC was 2.89% (85/3391). The age was between 24~88 years old, mean was 57.09±12.93 yrs. old, variable age of the VC had been juvenescence trend (F=6. 013, P=0.016). The differences between the urban and rural residential area have some influence to the onset of VC. Rural patients are more than urban patients. By statistical analysis, region distribution in these two groups was remarkably different=4.16,P=0.045<0.05, but the urban proportion of patients in different years has no difference (χ2=0.080, P=0.777). Conclusion: The number of cases increased progressively in young age. VC patients were more in rural area than urban. History of malignant tumor and obesity has the positive correlation with VC. High-risk groups should be alert to the possibility of VC. Preoperative diagnosis should be Colposcopic, biopsy in order to improve the accuracy of earlier diagnosis. Vulvar resects have an effect on the healing of the incision. Follow-up rate is low; It is difficult to say statistically survival rate is 5 years. [Int J Reprod Contracept Obstet Gynecol 2013; 2(3.000): 268-276
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.